Quanterix Corp
Digitizes biomarker analysis with an ultra-sensitive digital immunoassay platform.
QTRX | US
Overview
Corporate Details
- ISIN(s):
- US74766Q1013
- LEI:
- Country:
- United States of America
- Address:
- 900 MIDDLESEX TURNPIKE, 1821 BILLERICA
- Website:
- https://www.quanterix.com/
Description
Quanterix Corporation is a company focused on digitizing biomarker analysis to advance the science of precision health. Its core offering is the proprietary Simoa® technology, an ultra-sensitive digital immunoassay platform designed to detect and measure biomarkers at extremely low concentrations. This capability allows researchers to study the biology of health and disease with high precision, enabling earlier disease detection, improved prognoses, and the development of more effective treatment methods. The Simoa platform is utilized across a wide range of therapeutic areas, including a strategic focus on neurology (neurodegeneration, neuroinflammation, traumatic brain injuries), as well as oncology, cardiology, inflammation, and infectious diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Quanterix Corp filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Quanterix Corp
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Quanterix Corp via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
